{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:00:52Z","timestamp":1790402452352,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03930-8","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:48:54Z","timestamp":1740055734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tetrandrine induces cell cycle arrest in cutaneous melanoma cells by inhibiting IL-6\/CDC42 signaling"],"prefix":"10.1007","volume":"317","author":[{"given":"Liang","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuxiao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"10400","key":"3930_CR1","first-page":"485","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV et al (2023) Cutan Melanoma Lancet 402(10400):485\u2013502","journal-title":"Cutan Melanoma Lancet"},{"issue":"1","key":"3930_CR2","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41467-020-15546-9","volume":"11","author":"VW Rebecca","year":"2020","unstructured":"Rebecca VW, Somasundaram R, Herlyn M (2020) Pre-clinical modeling of cutaneous melanoma. Nat Commun 11(1):2858","journal-title":"Nat Commun"},{"issue":"1","key":"3930_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0002-9440(10)63110-0","volume":"164","author":"SR Alonso","year":"2004","unstructured":"Alonso SR et al (2004) Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am J Pathol 164(1):193\u2013203","journal-title":"Am J Pathol"},{"issue":"4","key":"3930_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/00313020600817951","volume":"38","author":"W Li","year":"2006","unstructured":"Li W et al (2006) The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology 38(4):287\u2013301","journal-title":"Pathology"},{"issue":"4","key":"3930_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/1098-2264(200008)28:4<404::AID-GCC6>3.0.CO;2-P","volume":"28","author":"I Sauroja","year":"2000","unstructured":"Sauroja I et al (2000) Analysis of G \/S checkpoint regulators in metastatic melanoma. Genes Chromosomes Cancer 28(4):404\u2013414","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"3930_CR6","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/jphp.13339","volume":"72","author":"F Luan","year":"2020","unstructured":"Luan F, He X, Zeng N (2020) Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems. J Pharm Pharmacol 72(11):1491\u20131512","journal-title":"J Pharm Pharmacol"},{"key":"3930_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.intimp.2016.04.039","volume":"36","author":"X Li","year":"2016","unstructured":"Li X et al (2016) Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-kappaB signaling. Int Immunopharmacol 36:263\u2013270","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"3930_CR8","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s10787-024-01452-9","volume":"32","author":"J Song","year":"2024","unstructured":"Song J et al (2024) Therapeutic effects of tetrandrine in inflammatory diseases: a comprehensive review. Inflammopharmacology 32(3):1743\u20131757","journal-title":"Inflammopharmacology"},{"issue":"3","key":"3930_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.4103\/1673-5374.179058","volume":"11","author":"YL Lv","year":"2016","unstructured":"Lv YL et al (2016) Neuroprotective effects of tetrandrine against vascular dementia. Neural Regen Res 11(3):454\u2013459","journal-title":"Neural Regen Res"},{"issue":"7Supplement","key":"3930_CR10","first-page":"467","volume":"64","author":"M Linghua","year":"2004","unstructured":"Linghua M et al (2004) Tetrandrine down-regulated CDK4 and CDK6 expression, and induced G1 cell cycle arrest in both p53-dependent and -independent ways. Cancer Res 64(7Supplement):467\u2013468","journal-title":"Cancer Res"},{"issue":"1","key":"3930_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11418-013-0765-0","volume":"68","author":"T Chen","year":"2014","unstructured":"Chen T, Ji B, Chen Y (2014) Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells. J Nat Med 68(1):46\u201352","journal-title":"J Nat Med"},{"key":"3930_CR12","doi-asserted-by":"publisher","first-page":"p164","DOI":"10.1016\/j.canlet.2018.03.042","volume":"425","author":"K Singh","year":"2018","unstructured":"Singh K et al (2018) Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: Differential regulation of p21(Cip1\/Waf1), p27(Kip1) and cyclin D1. Cancer Lett 425:p164\u2013173","journal-title":"Cancer Lett"},{"issue":"9","key":"3930_CR13","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari N et al (2016) Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol 37(9):11553\u201311572","journal-title":"Tumour Biol"},{"key":"3930_CR14","doi-asserted-by":"crossref","unstructured":"Raskova M et al (2022) The role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic opportunities. Cells, 11(22)","DOI":"10.3390\/cells11223698"},{"key":"3930_CR15","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.2147\/CMAR.S179189","volume":"10","author":"L Browning","year":"2018","unstructured":"Browning L et al (2018) IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis. Cancer Manag Res 10:6685\u20136693","journal-title":"Cancer Manag Res"},{"issue":"4","key":"3930_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR (2018) Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 15(4):234\u2013248","journal-title":"Nat Rev Clin Oncol"},{"key":"3930_CR17","doi-asserted-by":"publisher","first-page":"866014","DOI":"10.3389\/fonc.2022.866014","volume":"12","author":"SG Manore","year":"2022","unstructured":"Manore SG et al (2022) IL-6\/JAK\/STAT3 signaling in breast Cancer metastasis: Biology and Treatment. Front Oncol 12:866014","journal-title":"Front Oncol"},{"issue":"5","key":"3930_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/CMR.0b013e3283543d72","volume":"22","author":"L Hoejberg","year":"2012","unstructured":"Hoejberg L, Bastholt L, Schmidt H (2012) Interleukin-6 and melanoma. Melanoma Res 22(5):327\u2013333","journal-title":"Melanoma Res"},{"key":"3930_CR19","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.2147\/OTT.S324552","volume":"14","author":"SC Tsai","year":"2021","unstructured":"Tsai SC, Wu WC, Yang JS (2021) Tetrandrine inhibits epithelial-mesenchymal transition in IL-6-Induced HCT116 Human Colorectal Cancer cells. Onco Targets Ther 14:4523\u20134536","journal-title":"Onco Targets Ther"},{"issue":"1","key":"3930_CR20","doi-asserted-by":"publisher","first-page":"10407","DOI":"10.1038\/s41598-017-10891-0","volume":"7","author":"C Zheng","year":"2017","unstructured":"Zheng C et al (2017) Cell Division Cycle 42 plays a cell type-specific role in Lung Tumorigenesis. Sci Rep 7(1):10407","journal-title":"Sci Rep"},{"key":"3930_CR21","doi-asserted-by":"crossref","unstructured":"Xiao XH et al (2018) Regulating Cdc42 and its signaling pathways in Cancer: small molecules and MicroRNA as New Treatment candidates. Molecules, 23(4)","DOI":"10.3390\/molecules23040787"},{"issue":"28","key":"3930_CR22","doi-asserted-by":"publisher","first-page":"11143","DOI":"10.1074\/jbc.RA118.003276","volume":"293","author":"GL Razidlo","year":"2018","unstructured":"Razidlo GL, Burton KM, McNiven MA (2018) Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42. J Biol Chem 293(28):11143\u201311153","journal-title":"J Biol Chem"},{"key":"3930_CR23","doi-asserted-by":"crossref","unstructured":"Piyu PN (2021) Cutaneous malignant melanoma: a review of early diagnosis and management. World J Oncol 12(1):7\u201319","DOI":"10.14740\/wjon1349"},{"issue":"3","key":"3930_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3892\/etm.2023.12115","volume":"26","author":"Z Qin","year":"2023","unstructured":"Qin Z, Zheng M (2023) Advances in targeted therapy and immunotherapy for melanoma (review). Exp Ther Med 26(3):416","journal-title":"Exp Ther Med"},{"issue":"12","key":"3930_CR25","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/annonc\/mdz411","volume":"30","author":"O Michielin","year":"2019","unstructured":"Michielin O et al (2019) Cutaneous melanoma: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-updagger. Ann Oncol 30(12):1884\u20131901","journal-title":"Ann Oncol"},{"issue":"1","key":"3930_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","volume":"32","author":"J Liu","year":"2022","unstructured":"Liu J, Peng Y, Wei W (2022) Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends Cell Biol 32(1):30\u201344","journal-title":"Trends Cell Biol"},{"issue":"1","key":"3930_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews HK, Bertoli C, de Bruin RAM (2022) Cell cycle control in cancer. Nat Rev Mol Cell Biol 23(1):74\u201388","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"3930_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4161\/cbt.7.7.6142","volume":"7","author":"XL Chen","year":"2008","unstructured":"Chen XL et al (2008) Involvement of PI3K\/AKT\/GSK3beta pathway in tetrandrine-induced G1 arrest and apoptosis. Cancer Biol Ther 7(7):1073\u20131078","journal-title":"Cancer Biol Ther"},{"key":"3930_CR29","doi-asserted-by":"crossref","unstructured":"Meng LH et al (2004) Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res, 64(24): pp. 9086-92","DOI":"10.1158\/0008-5472.CAN-04-0313"},{"issue":"6","key":"3930_CR30","first-page":"1239","volume":"21","author":"JH Lee","year":"2002","unstructured":"Lee JH et al (2002) Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells. Int J Oncol 21(6):1239\u20131244","journal-title":"Int J Oncol"},{"issue":"2","key":"3930_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0024-3205(03)00266-2","volume":"73","author":"PL Kuo","year":"2003","unstructured":"Kuo PL, Lin CC (2003) Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells. Life Sci 73(2):243\u2013252","journal-title":"Life Sci"},{"key":"3930_CR32","doi-asserted-by":"crossref","unstructured":"Izraely S et al (2023) The vicious cycle of Melanoma-Microglia Crosstalk: Inter-melanoma variations in the brain-metastasis-promoting IL-6\/JAK\/STAT3 signaling pathway. Cells, 12(11)","DOI":"10.3390\/cells12111513"},{"issue":"3","key":"3930_CR33","doi-asserted-by":"publisher","first-page":"800","DOI":"10.7150\/jca.65415","volume":"13","author":"J Fu","year":"2022","unstructured":"Fu J et al (2022) The role of cell division control protein 42 in tumor and non-tumor diseases: a systematic review. J Cancer 13(3):800\u2013814","journal-title":"J Cancer"},{"issue":"5228","key":"3930_CR34","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1126\/science.7652575","volume":"269","author":"MF Olson","year":"1995","unstructured":"Olson MF, Ashworth A, Hall A (1995) An essential role for rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Sci (New York N Y) 269(5228):1270\u20131272","journal-title":"Sci (New York N Y)"},{"issue":"10","key":"3930_CR35","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41419-020-03094-5","volume":"11","author":"P Xiang","year":"2020","unstructured":"Xiang P et al (2020) HCF-1 promotes cell cycle progression by regulating the expression of CDC42. Cell Death Dis 11(10):907","journal-title":"Cell Death Dis"},{"issue":"6","key":"3930_CR36","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1080\/15384047.2018.1564559","volume":"20","author":"BJ Aguilar","year":"2019","unstructured":"Aguilar BJ et al (2019) Inhibition of Cdc42-intersectin interaction by small molecule ZCL367 impedes cancer cell cycle progression, proliferation, migration, and tumor growth. Cancer Biol Ther 20(6):740\u2013749","journal-title":"Cancer Biol Ther"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03930-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03930-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03930-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:48:59Z","timestamp":1740055739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03930-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3930"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03930-8","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"442"}}